FCWGX | MGLVX | FCWGX / MGLVX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 12 years | - |
Gain YTD | 13.337 | 13.076 | 102% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 125B | 437M | 28,604% |
Annual Yield % from dividends | 1.91 | 1.78 | 107% |
Returns for 1 year | 19.38 | 18.14 | 107% |
Returns for 3 years | 6.16 | -4.27 | -144% |
Returns for 5 years | N/A | 13.81 | - |
Returns for 10 years | N/A | 37.50 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WFEAX | 12.53 | -0.06 | -0.48% |
Allspring International Equity A | |||
LQFLX | 13.62 | -0.09 | -0.66% |
Lord Abbett Focused Large Cap Value R3 | |||
PJFOX | 71.43 | -1.62 | -2.22% |
PGIM Jennison Growth R2 | |||
PLXGX | 24.63 | -0.58 | -2.30% |
Virtus KAR Capital Growth I | |||
FBTIX | 32.77 | -1.67 | -4.85% |
Fidelity Advisor Biotechnology I |